Literature DB >> 8552629

Estrogens increase the expression of fibulin-1, an extracellular matrix protein secreted by human ovarian cancer cells.

G M Clinton1, C Rougeot, J Derancourt, P Roger, A Defrenne, S Godyna, W S Argraves, H Rochefort.   

Abstract

Ovarian cancers have a high ability to invade the peritoneal cavity and some are stimulated by estrogens. In an attempt to understand the mode of action of estrogens on these cancer cells and to develop new markers, we have characterized estrogen-regulated proteins. This study was aimed at identifying a protein secreted by ovarian cancer cells whose level was increased by estradiol [Galtier-Dereure, F., Capony, F., Maudelonde, T. & Rochefort, H. (1992) J. Clin. Endocrinol. Metab. 75, 1497-1502]. By using microprotein sequencing, the 110-kDa protein was identified as fibulin-1, a protein of the extracellular matrix that binds to fibronectin, laminin, and nidogen. The amount of immunoprecipitated fibulin-1 secreted into the medium and present in the cell extract was increased up to 10-fold by estradiol in three estrogen-responsive ovarian cancer cell lines. By immunohistochemistry fibulin-1 was located in the stroma of several ovarian cancers and cysts. The findings highlight a potential role for fibulin-1 in the spread of ovarian cancer in the peritoneal cavity and/or in distal metastases.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8552629      PMCID: PMC40229          DOI: 10.1073/pnas.93.1.316

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  26 in total

1.  The extracellular matrix glycoproteins BM-90 and tenascin are expressed in the mesenchyme at sites of endothelial-mesenchymal conversion in the embryonic mouse heart.

Authors:  H Y Zhang; M Kluge; R Timpl; M L Chu; P Ekblom
Journal:  Differentiation       Date:  1993-03       Impact factor: 3.880

2.  Transcriptional activation of c-myc proto-oncogene by estrogen in human ovarian cancer cells.

Authors:  C H Chien; F F Wang; T C Hamilton
Journal:  Mol Cell Endocrinol       Date:  1994-02       Impact factor: 4.102

3.  The effects of estrogens and antiestrogens on hormone-responsive human breast cancer in long-term tissue culture.

Authors:  M Lippman; G Bolan; K Huff
Journal:  Cancer Res       Date:  1976-12       Impact factor: 12.701

4.  The interaction of fibulin-1 with fibrinogen. A potential role in hemostasis and thrombosis.

Authors:  H Tran; A Tanaka; S V Litvinovich; L V Medved; C C Haudenschild; W S Argraves
Journal:  J Biol Chem       Date:  1995-08-18       Impact factor: 5.157

5.  The regulation of growth and protein expression by estrogen in vitro: a study of 8 human ovarian carcinoma cell lines.

Authors:  S P Langdon; G L Hirst; E P Miller; R A Hawkins; A L Tesdale; J F Smyth; W R Miller
Journal:  J Steroid Biochem Mol Biol       Date:  1994-08       Impact factor: 4.292

6.  Estrogen replacement therapy and fatal ovarian cancer.

Authors:  C Rodriguez; E E Calle; R J Coates; H L Miracle-McMahill; M J Thun; C W Heath
Journal:  Am J Epidemiol       Date:  1995-05-01       Impact factor: 4.897

7.  SKOV3 ovarian carcinoma cells have functional estrogen receptor but are growth-resistant to estrogen and antiestrogens.

Authors:  W Hua; T Christianson; C Rougeot; H Rochefort; G M Clinton
Journal:  J Steroid Biochem Mol Biol       Date:  1995-12       Impact factor: 4.292

8.  Estradiol stimulates cell growth and secretion of procathepsin D and a 120-kilodalton protein in the human ovarian cancer cell line BG-1.

Authors:  F Galtier-Dereure; F Capony; T Maudelonde; H Rochefort
Journal:  J Clin Endocrinol Metab       Date:  1992-12       Impact factor: 5.958

9.  Localization of the human gene for fibulin-1 (FBLN1) to chromosome band 22q13.3.

Authors:  J R Korenberg; X N Chen; H Tran; W S Argraves
Journal:  Cytogenet Cell Genet       Date:  1995

10.  The association of human fibulin-1 with elastic fibers: an immunohistological, ultrastructural, and RNA study.

Authors:  E F Roark; D R Keene; C C Haudenschild; S Godyna; C D Little; W S Argraves
Journal:  J Histochem Cytochem       Date:  1995-04       Impact factor: 2.479

View more
  19 in total

Review 1.  Fibulins: physiological and disease perspectives.

Authors:  W Scott Argraves; Lisa M Greene; Marion A Cooley; William M Gallagher
Journal:  EMBO Rep       Date:  2003-12       Impact factor: 8.807

2.  A high-throughput cell-based Gaussia luciferase reporter assay for identifying modulators of fibulin-3 secretion.

Authors:  John D Hulleman; Steven J Brown; Hugh Rosen; Jeffery W Kelly
Journal:  J Biomol Screen       Date:  2012-12-10

3.  Structural and functional characterization of the human and mouse fibulin-1 gene promoters: role of Sp1 and Sp3.

Authors:  Mirco Castoldi; Mon-Li Chu
Journal:  Biochem J       Date:  2002-02-15       Impact factor: 3.857

4.  Innate-like functions of natural killer T cell subsets result from highly divergent gene programs.

Authors:  Isaac Engel; Grégory Seumois; Lukas Chavez; Daniela Samaniego-Castruita; Brandie White; Ashu Chawla; Dennis Mock; Pandurangan Vijayanand; Mitchell Kronenberg
Journal:  Nat Immunol       Date:  2016-04-18       Impact factor: 25.606

5.  Selection and identification of ligand peptides targeting a model of castrate-resistant osteogenic prostate cancer and their receptors.

Authors:  Jami Mandelin; Marina Cardó-Vila; Wouter H P Driessen; Paul Mathew; Nora M Navone; Sue-Hwa Lin; Christopher J Logothetis; Anna Cecilia Rietz; Andrey S Dobroff; Bettina Proneth; Richard L Sidman; Renata Pasqualini; Wadih Arap
Journal:  Proc Natl Acad Sci U S A       Date:  2015-03-11       Impact factor: 11.205

Review 6.  Hormone response in ovarian cancer: time to reconsider as a clinical target?

Authors:  Francesmary Modugno; Robin Laskey; Ashlee L Smith; Courtney L Andersen; Paul Haluska; Steffi Oesterreich
Journal:  Endocr Relat Cancer       Date:  2012-11-09       Impact factor: 5.678

7.  Tamoxifen and the risk of ovarian cancer in BRCA1 mutation carriers.

Authors:  Danielle Vicus; Barry Rosen; Jan Lubinski; Susan Domchek; Noah D Kauff; Henry T Lynch; Claudine Isaacs; Nadine Tung; Ping Sun; Steven A Narod
Journal:  Gynecol Oncol       Date:  2009-07-03       Impact factor: 5.482

8.  Glycoproteomic Analysis of Malignant Ovarian Cancer Ascites Fluid Identifies Unusual Glycopeptides.

Authors:  Suzanne Miyamoto; L Renee Ruhaak; Carol Stroble; Michelle R Salemi; Brett Phinney; Carlito B Lebrilla; Gary S Leiserowitz
Journal:  J Proteome Res       Date:  2016-08-23       Impact factor: 4.466

Review 9.  New insights on the role of hormonal therapy in ovarian cancer.

Authors:  Fiona Simpkins; Arlene Garcia-Soto; Joyce Slingerland
Journal:  Steroids       Date:  2013-02-08       Impact factor: 2.668

10.  BG-1 ovarian cell line: an alternative model for examining estrogen-dependent growth in vitro.

Authors:  W S Baldwin; S W Curtis; C A Cauthen; J I Risinger; K S Korach; J C Barrett
Journal:  In Vitro Cell Dev Biol Anim       Date:  1998-09       Impact factor: 2.416

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.